Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection.

The Journal of infectious diseases - 1 Aug 2014

Wilson Lauren, Pawlita Michael, Castle Phillip E, Waterboer Tim, Sahasrabuddhe Vikrant, Gravitt Patti E, Schiffman Mark, Wentzensen Nicolas

Abstract excerpt

BACKGROUND: Natural human papillomavirus (HPV) antibody titers have shown protection against subsequent HPV infection, but previous studies were restricted to few HPV genotypes. We examined the association of naturally occurring antibodies against 8 carcinogenic HPV types with subsequent infections. METHODS: A total of 2302 women enrolled in the Atypical Squamous Cells of Undetermined Significance/Low-Grade...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptive Immunity
Share to Cervical Cancer and HPV Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Odds Ratio

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Seroepidemiologic Studies

Share to Uterine Cervical Dysplasia

Source

Open in PubMed Open full text

Identifiers

PMID: 24569064
DOI: 10.1093/infdis/jiu104
PMCID: PMC4110458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection.PMID 24569064Read ↗

Human Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical PrecancerSemantic proximity Read ↗

Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesSemantic proximity Read ↗

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.Semantic proximity Read ↗

Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study.Semantic proximity Read ↗

Seroprevalences of Antibodies to 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure.Semantic proximity Read ↗

Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.Semantic proximity Read ↗

Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study.Semantic proximity Read ↗

High-risk human papillomavirus genotyping in women with atypical squamous cells of undetermined significance.Semantic proximity Read ↗

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?Semantic proximity Read ↗

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.Semantic proximity Read ↗

Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.Semantic proximity Read ↗

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.